Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 2 | 2023 | 1037 | 0.950 |
Why?
|
| Esophagogastric Junction | 3 | 2023 | 351 | 0.790 |
Why?
|
| Capsid | 1 | 2023 | 435 | 0.710 |
Why?
|
| Stomach | 2 | 2016 | 699 | 0.640 |
Why?
|
| Gastric Mucosa | 2 | 2011 | 602 | 0.580 |
Why?
|
| Genes, p16 | 1 | 2018 | 157 | 0.570 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 898 | 0.540 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 1471 | 0.530 |
Why?
|
| Transgenes | 1 | 2019 | 1015 | 0.520 |
Why?
|
| Esophageal Neoplasms | 3 | 2023 | 1661 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 703 | 0.470 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 1216 | 0.460 |
Why?
|
| Carcinoma | 2 | 2016 | 2312 | 0.450 |
Why?
|
| Adenocarcinoma | 6 | 2023 | 6364 | 0.410 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 2505 | 0.380 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 512 | 0.380 |
Why?
|
| Genetic Markers | 1 | 2018 | 2601 | 0.380 |
Why?
|
| Pathology, Clinical | 1 | 2015 | 377 | 0.380 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 790 | 0.370 |
Why?
|
| Dependovirus | 2 | 2023 | 721 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2176 | 0.250 |
Why?
|
| Esophagus | 1 | 2011 | 1037 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2011 | 888 | 0.230 |
Why?
|
| Barrett Esophagus | 2 | 2023 | 494 | 0.220 |
Why?
|
| Genetic Vectors | 2 | 2023 | 3404 | 0.190 |
Why?
|
| Interleukin-18 | 1 | 2022 | 251 | 0.180 |
Why?
|
| Capsid Proteins | 1 | 2023 | 467 | 0.170 |
Why?
|
| Tropism | 1 | 2019 | 44 | 0.170 |
Why?
|
| Foam Cells | 1 | 2020 | 67 | 0.170 |
Why?
|
| Macrophages, Peritoneal | 1 | 2020 | 243 | 0.160 |
Why?
|
| Survival Rate | 4 | 2023 | 12795 | 0.160 |
Why?
|
| Cholesterol, Dietary | 1 | 2019 | 223 | 0.150 |
Why?
|
| Fetal Proteins | 1 | 2019 | 99 | 0.150 |
Why?
|
| Antigens, Ly | 1 | 2019 | 296 | 0.150 |
Why?
|
| Cell Degranulation | 1 | 2019 | 280 | 0.150 |
Why?
|
| Macrophage Activation | 1 | 2020 | 552 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 469 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2023 | 1341 | 0.130 |
Why?
|
| Eosinophils | 1 | 2020 | 945 | 0.130 |
Why?
|
| Chordoma | 1 | 2019 | 343 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 833 | 0.120 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 139 | 0.120 |
Why?
|
| Pancreas | 1 | 2022 | 1700 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2023 | 2887 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 898 | 0.120 |
Why?
|
| Gastroscopy | 1 | 2016 | 213 | 0.110 |
Why?
|
| Chemokine CCL20 | 1 | 2014 | 64 | 0.110 |
Why?
|
| Receptors, CCR6 | 1 | 2014 | 73 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2015 | 251 | 0.110 |
Why?
|
| Genes, APC | 1 | 2014 | 144 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2020 | 1481 | 0.110 |
Why?
|
| CA-125 Antigen | 1 | 2016 | 283 | 0.110 |
Why?
|
| Gene Amplification | 1 | 2018 | 1091 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2015 | 566 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1118 | 0.100 |
Why?
|
| Helicobacter Infections | 1 | 2016 | 390 | 0.100 |
Why?
|
| Prognosis | 4 | 2023 | 29922 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 11206 | 0.100 |
Why?
|
| Aorta | 1 | 2020 | 2028 | 0.100 |
Why?
|
| Aging | 1 | 2011 | 8731 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1668 | 0.100 |
Why?
|
| Mast Cells | 1 | 2019 | 1412 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 2008 | 976 | 0.090 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 313 | 0.090 |
Why?
|
| Pancreatectomy | 1 | 2016 | 820 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 587 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1187 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2015 | 1816 | 0.090 |
Why?
|
| Metaplasia | 1 | 2011 | 326 | 0.080 |
Why?
|
| Mice | 8 | 2023 | 81819 | 0.080 |
Why?
|
| China | 1 | 2016 | 2385 | 0.080 |
Why?
|
| Asia | 1 | 2011 | 628 | 0.080 |
Why?
|
| Ploidies | 1 | 2008 | 287 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 5444 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 647 | 0.070 |
Why?
|
| North America | 1 | 2011 | 1285 | 0.070 |
Why?
|
| Autopsy | 1 | 2011 | 1011 | 0.070 |
Why?
|
| Obesity | 2 | 2020 | 13076 | 0.070 |
Why?
|
| Animals | 10 | 2023 | 168764 | 0.070 |
Why?
|
| Fluorouracil | 1 | 2011 | 1648 | 0.060 |
Why?
|
| Humans | 18 | 2023 | 765968 | 0.060 |
Why?
|
| Cell Line | 1 | 2019 | 15543 | 0.060 |
Why?
|
| Health | 1 | 2008 | 397 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2006 | 1602 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11022 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6499 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2844 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6610 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1789 | 0.060 |
Why?
|
| Europe | 1 | 2011 | 3423 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2020 | 3424 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2521 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 6942 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11499 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7851 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 2531 | 0.050 |
Why?
|
| Male | 12 | 2020 | 363698 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2002 | 139 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 1242 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2008 | 961 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12509 | 0.040 |
Why?
|
| Heart | 2 | 2006 | 4414 | 0.040 |
Why?
|
| Neurons | 1 | 2019 | 9525 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22332 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2020 | 265 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 10850 | 0.040 |
Why?
|
| Sterols | 1 | 2020 | 63 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 2020 | 253 | 0.040 |
Why?
|
| Ketotifen | 1 | 2019 | 24 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2019 | 43 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 373 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2019 | 12131 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3596 | 0.040 |
Why?
|
| Biopsy | 1 | 2011 | 6763 | 0.040 |
Why?
|
| Streptozocin | 1 | 2019 | 189 | 0.040 |
Why?
|
| Cromolyn Sodium | 1 | 2019 | 76 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 1241 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2016 | 81514 | 0.040 |
Why?
|
| Female | 8 | 2020 | 396112 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 2020 | 374 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 802 | 0.040 |
Why?
|
| Cytokines | 2 | 2020 | 7421 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2019 | 153 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3046 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2019 | 185 | 0.040 |
Why?
|
| Histamine | 1 | 2019 | 497 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2020 | 1162 | 0.030 |
Why?
|
| Middle Aged | 5 | 2018 | 223009 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2019 | 491 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 6220 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5337 | 0.030 |
Why?
|
| Stem Cells | 1 | 2008 | 3540 | 0.030 |
Why?
|
| Cell Death | 1 | 2020 | 1679 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 660 | 0.030 |
Why?
|
| Myocardium | 3 | 2020 | 4760 | 0.030 |
Why?
|
| DNA | 1 | 2008 | 7202 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 171117 | 0.030 |
Why?
|
| Serotonin | 1 | 2019 | 1049 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18380 | 0.030 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 572 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15747 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 741 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 27171 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 59489 | 0.030 |
Why?
|
| Adult | 2 | 2018 | 223044 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2019 | 2927 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14448 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2011 | 89 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1748 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1701 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1884 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10429 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2020 | 6404 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2020 | 4159 | 0.020 |
Why?
|
| SEER Program | 1 | 2015 | 1446 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2476 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 2393 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 59889 | 0.020 |
Why?
|
| Image Cytometry | 1 | 2008 | 51 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2020 | 1529 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9550 | 0.020 |
Why?
|
| Insulin | 1 | 2022 | 6599 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 88835 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3312 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4562 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 1837 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5020 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6113 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7584 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 23601 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 2630 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3985 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6424 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18973 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39193 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1377 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8875 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3608 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5696 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7838 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3421 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2002 | 149 | 0.010 |
Why?
|
| Necrosis | 1 | 2006 | 1617 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 2195 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18293 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2060 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 402 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 2895 | 0.010 |
Why?
|
| Intestines | 1 | 2008 | 1906 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8529 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12768 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9514 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4025 | 0.010 |
Why?
|
| Adenoma | 1 | 2008 | 2152 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1884 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 21480 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4331 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2002 | 1515 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40065 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13648 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5747 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 8923 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 4184 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3890 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2002 | 3928 | 0.000 |
Why?
|
| United States | 1 | 2015 | 72903 | 0.000 |
Why?
|
| Rats | 1 | 2002 | 23707 | 0.000 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_